Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
By Daphne Psaledakis, Simon Lewis and Elias Biryabarema WASHINGTON (Reuters) -About 1,000 doses of Gilead Sciences Inc's drug ...
Activists have sharply criticised the US government’s move to exclude South Africa from receiving HIV prevention medication ...
LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
The drug lenacapavir will be distributed to Eswatini and Zambia — the first step toward providing at least 2 million doses to ...
Trump administration touts moves to provide HIV prevention drug, but refuses to include South Africa
The US has started to provide doses of a Gilead HIV prevention drug to low-income countries, but the program will not include ...
Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...
China will finance HIV-prevention programs in South Africa for the first time, taking a small step into the massive void left by US funding cuts earlier this year.
The South African on MSN
The HIV-prevention jab is here: What you need to know…
You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Health ...
News Medical on MSN
Medicaid Expansion Increases Access to HIV Prevention Medication for High-Risk Populations
Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...
Deniz Gökengin thinks colleagues view her as “a very serious, hardworking, meticulous, control-freak type of person”. But she ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results